Today, Vireo Advisors is joining the NNI and nanotechnology-related organizations around the US in celebrating the 20th anniversary of the 21st Century Nanotechnology Research and Development Act.

The 2023 Nobel Prize in Chemistry shines a light on the extraordinary properties of nanoscale materials, but the story of quantum dots commercialization is far from over. Work on ‘safer-by-design’ approaches, including Vireo's first Life Cycle Risk Assessment for quantum dots, and our current work on graphene oxide with European partners of the DIAGONAL project aims towards new generations of highly fluorescent nanoparticles and remarkable new products.

We take pride in our diverse and inclusive workforce, with employees from different nationalities, ages, and gender identities. We benefit from a rich tapestry of perspectives, resulting in enhanced decision-making and innovation.

Cell survival, proliferation, and function rely on a complex array of nutritional, hormonal, and stromal cues, and companies are looking for animal-free culture and growth media that can provide the correct chemical environments for cultured meat production

Our latest roundup includes news about regulatory actions on nanomaterials, food additives, bisphenols and partially hydrogenated oils; new databases for exposure assessment data and regulatory information; company news from UBQ, Performance Biofilaments Inc., Conagen and Amyris, Inc.; and publication of notable papers on safety assessment and safe and sustainable by design (SSbD) approaches.